<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35843340</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>06</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8392</ISSN><JournalIssue CitedMedium="Internet"><Volume>132</Volume><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Human pathology</Title><ISOAbbreviation>Hum Pathol</ISOAbbreviation></Journal><ArticleTitle>COVID-19: gastrointestinal and hepatobiliary manifestations.</ArticleTitle><Pagination><StartPage>39</StartPage><EndPage>55</EndPage><MedlinePgn>39-55</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.humpath.2022.07.006</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0046-8177(22)00179-4</ELocationID><Abstract><AbstractText>SARS-CoV-2 is the viral agent of COVID-19, a pandemic that surfaced in 2019. Although predominantly a respiratory ailment, patients with COVID-19 can have gastrointestinal (GI) and hepatobiliary manifestations. These manifestations are often mild and transient, but they can be severe and consequential. In the GI tract, ischemic enterocolitis is the most common and significant consequence of COVID-19. In the liver, the reported pathologic findings may often be related to consequences of severe systemic viral infection, but reports of hepatitis presumed to be due to SARS-CoV-2 suggest that direct viral infection of the liver may be a rare complication of COVID-19. In both the GI tract and liver, lingering symptoms of GI or hepatic injury after resolution of pulmonary infection may be part of the evolving spectrum of long COVID.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shih</LastName><ForeName>Angela R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. Electronic address: ashih1@partners.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Misdraji</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pathology, Yale New Haven Hospital, Yale University, New Haven, CT, 06510, USA. Electronic address: joseph.misdraji@yale.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Hum Pathol</MedlineTA><NlmUniqueID>9421547</NlmUniqueID><ISSNLinking>0046-8177</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005767" MajorTopicYN="Y">Gastrointestinal Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D041981" MajorTopicYN="N">Gastrointestinal Tract</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Colon</Keyword><Keyword MajorTopicYN="N">Gastrointestinal</Keyword><Keyword MajorTopicYN="N">Liver</Keyword><Keyword MajorTopicYN="N">Pathology</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>17</Day><Hour>19</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35843340</ArticleId><ArticleId IdType="pmc">PMC9288242</ArticleId><ArticleId IdType="doi">10.1016/j.humpath.2022.07.006</ArticleId><ArticleId IdType="pii">S0046-8177(22)00179-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhang H., Liao Y.-S., Gong J., et al. Clinical characteristics of coronavirus disease (COVID-19) patients with gastrointestinal symptoms: a report of 164 cases. Dig Liver Dis. 2020;52:1076&#x2013;1079. doi: 10.1016/j.dld.2020.04.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dld.2020.04.034</ArticleId><ArticleId IdType="pmc">PMC7205655</ArticleId><ArticleId IdType="pubmed">32507692</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajifathalian K., Krisko T., Mehta A., et al. Gastrointestinal and hepatic manifestations of 2019 novel coronavirus disease in a large cohort of infected patients from New York: clinical implications. Gastroenterology. 2020;159:1137&#x2013;1140. doi: 10.1053/j.gastro.2020.05.010. e2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.05.010</ArticleId><ArticleId IdType="pmc">PMC7205652</ArticleId><ArticleId IdType="pubmed">32389667</ArticleId></ArticleIdList></Reference><Reference><Citation>Elmunzer B.J., Spitzer R.L., Foster L.D., et al. Digestive manifestations in patients hospitalized with coronavirus disease 2019. Clin Gastroenterol Hepatol. 2021;19:1355&#x2013;1365. doi: 10.1016/j.cgh.2020.09.041. e4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2020.09.041</ArticleId><ArticleId IdType="pmc">PMC7527302</ArticleId><ArticleId IdType="pubmed">33010411</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao T.-T., Zhang G.-Q., Pellegrini E., et al. COVID-19 and its effects on the digestive system. World J Gastroenterol. 2021;27:3502&#x2013;3515. doi: 10.3748/wjg.v27.i24.3502.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v27.i24.3502</ArticleId><ArticleId IdType="pmc">PMC8240057</ArticleId><ArticleId IdType="pubmed">34239265</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung K.S., Hung I.F.N., Chan P.P.Y., et al. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong cohort: systematic review and meta-analysis. Gastroenterology. 2020;159:81&#x2013;95. doi: 10.1053/j.gastro.2020.03.065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.03.065</ArticleId><ArticleId IdType="pmc">PMC7194936</ArticleId><ArticleId IdType="pubmed">32251668</ArticleId></ArticleIdList></Reference><Reference><Citation>Docherty A.B., Harrison E.M., Green C.A., et al. Features of 20 133 UK patients in hospital with COVID-19 using the ISARIC WHO clinical characterisation protocol: prospective observational cohort study. BMJ. 2020;369:m1985. doi: 10.1136/bmj.m1985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1985</ArticleId><ArticleId IdType="pmc">PMC7243036</ArticleId><ArticleId IdType="pubmed">32444460</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan L., Mu M., Yang P., et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am J Gastroenterol. 2020;115 doi: 10.14309/ajg.0000000000000620.</Citation><ArticleIdList><ArticleId IdType="doi">10.14309/ajg.0000000000000620</ArticleId><ArticleId IdType="pmc">PMC7172492</ArticleId><ArticleId IdType="pubmed">32287140</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakhli R.E., Shanker A., Sarosiek I., et al. Gastrointestinal symptoms and the severity of COVID-19: disorders of gut&#x2013;brain interaction are an outcome. Neurogastroent Motil. 2022 doi: 10.1111/nmo.14368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nmo.14368</ArticleId><ArticleId IdType="pmc">PMC9115309</ArticleId><ArticleId IdType="pubmed">35383423</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng W., Qi K., Ye M., et al. Gastrointestinal symptoms are associated with severity of coronavirus disease 2019: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2021;34:168&#x2013;176. doi: 10.1097/meg.0000000000002072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/meg.0000000000002072</ArticleId><ArticleId IdType="pubmed">33470700</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng T., Yang C., Wang H., et al. Clinical characteristics and outcomes of COVID-19 patients with gastrointestinal symptoms admitted to Jianghan Fangcang Shelter Hospital in Wuhan, China. J Med Virol. 2020;92:2735&#x2013;2741. doi: 10.1002/jmv.26146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26146</ArticleId><ArticleId IdType="pmc">PMC7300864</ArticleId><ArticleId IdType="pubmed">32510173</ArticleId></ArticleIdList></Reference><Reference><Citation>Livanos A.E., Jha D., Cossarini F., et al. Intestinal host response to SARS-CoV-2 infection and COVID-19 outcomes in patients with gastrointestinal symptoms. Gastroenterology. 2021;160:2435&#x2013;2450. doi: 10.1053/j.gastro.2021.02.056. e34.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2021.02.056</ArticleId><ArticleId IdType="pmc">PMC7931673</ArticleId><ArticleId IdType="pubmed">33676971</ArticleId></ArticleIdList></Reference><Reference><Citation>Shehab M., Alrashed F., Shuaibi S., Alajmi D., Barkun A. Gastroenterological and hepatic manifestations of patients with COVID-19, prevalence, mortality by country, and intensive care admission rate: systematic review and meta-analysis. BMJ Open Gastroenterol. 2021;8 doi: 10.1136/bmjgast-2020-000571.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgast-2020-000571</ArticleId><ArticleId IdType="pmc">PMC7934201</ArticleId><ArticleId IdType="pubmed">33664052</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabesh E., Soheilipour M., Sami R., et al. Gastrointestinal manifestations in patients with coronavirus disease-2019 (COVID-19): impact on clinical outcomes. J Res Medical Sci Official J Isfahan&#xa0;Univ Medical Sci. 2022;27:32. doi: 10.4103/jrms.jrms_641_21.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jrms.jrms_641_21</ArticleId><ArticleId IdType="pmc">PMC9081509</ArticleId><ArticleId IdType="pubmed">35548178</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M.L., Jacobsen F., Pepe-Mooney B.J. Clinicopathological findings in patients with COVID-19-associated ischaemic enterocolitis. Histopathology. 2021;79:1004&#x2013;1017. doi: 10.1111/his.14457.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/his.14457</ArticleId><ArticleId IdType="pmc">PMC8444633</ArticleId><ArticleId IdType="pubmed">34292620</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhayana R., Som A., Li M.D., et al. Abdominal imaging findings in COVID-19: preliminary observations. Radiology. 2020;297 doi: 10.1148/radiol.2020201908.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020201908</ArticleId><ArticleId IdType="pmc">PMC7508000</ArticleId><ArticleId IdType="pubmed">32391742</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui M., Wang Q., Xin A.W., et al. Vascular thrombosis and vasculitis in the gastrointestinal tract are associated with poor prognosis in patients with COVID-19 - PubMed. Int J Clin Exp Pathol. 2021;14:1069&#x2013;1079.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8661070</ArticleId><ArticleId IdType="pubmed">34900075</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel S., Parikh C., Verma D., et al. Bowel ischemia in COVID-19: a systematic review. Int J Clin Pract. 2021;75 doi: 10.1111/ijcp.14930.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14930</ArticleId><ArticleId IdType="pmc">PMC8646310</ArticleId><ArticleId IdType="pubmed">34605117</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunt R.H., East J.E., Lanas A., et al. COVID-19 and gastrointestinal disease: implications for the gastroenterologist. Dig Dis Basel Switz. 2020;39:1&#x2013;21. doi: 10.1159/000512152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000512152</ArticleId><ArticleId IdType="pmc">PMC7705947</ArticleId><ArticleId IdType="pubmed">33040064</ArticleId></ArticleIdList></Reference><Reference><Citation>Han C., Duan C., Zhang S., et al. Digestive symptoms in COVID-19 patients with mild disease severity: clinical presentation, stool viral RNA testing, and outcomes. Am J Gastroenterol. 2020;115 doi: 10.14309/ajg.0000000000000664.</Citation><ArticleIdList><ArticleId IdType="doi">10.14309/ajg.0000000000000664</ArticleId><ArticleId IdType="pmc">PMC7172493</ArticleId><ArticleId IdType="pubmed">32301761</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Xu Y., Gao R., et al. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA. 2020;323:1843&#x2013;1844. doi: 10.1001/jama.2020.3786.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.3786</ArticleId><ArticleId IdType="pmc">PMC7066521</ArticleId><ArticleId IdType="pubmed">32159775</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao F., Tang M., Zheng X., Liu Y., Li X., Shan H. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 2020;158:1831&#x2013;1833. doi: 10.1053/j.gastro.2020.02.055. e3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.02.055</ArticleId><ArticleId IdType="pmc">PMC7130181</ArticleId><ArticleId IdType="pubmed">32142773</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao F., Sun J., Xu Y., et al. Infectious SARS-CoV-2 in feces of patient with severe COVID-19. Emerg Infect Dis. 2020;26:1920&#x2013;1922. doi: 10.3201/eid2608.200681.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2608.200681</ArticleId><ArticleId IdType="pmc">PMC7392466</ArticleId><ArticleId IdType="pubmed">32421494</ArticleId></ArticleIdList></Reference><Reference><Citation>Zang R., Castro M.F.G., McCune B.T., et al. TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes. Sci Immunol. 2020;5 doi: 10.1126/sciimmunol.abc3582.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abc3582</ArticleId><ArticleId IdType="pmc">PMC7285829</ArticleId><ArticleId IdType="pubmed">32404436</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanella G., Capurso G., Burti C., et al. Gastrointestinal mucosal damage in patients with COVID-19 undergoing endoscopy: an international multicentre study. BMJ Open Gastroenterol. 2021;8 doi: 10.1136/bmjgast-2020-000578.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgast-2020-000578</ArticleId><ArticleId IdType="pmc">PMC7907837</ArticleId><ArticleId IdType="pubmed">33627313</ArticleId></ArticleIdList></Reference><Reference><Citation>Yantiss R.K., Qin L., He B., et al. Intestinal abnormalities in patients with SARS-CoV-2 infection. Am J Surg Pathol. 2022;46:89&#x2013;96. doi: 10.1097/pas.0000000000001755.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/pas.0000000000001755</ArticleId><ArticleId IdType="pubmed">34081038</ArticleId></ArticleIdList></Reference><Reference><Citation>Massironi S., Vigan&#xf2; C., Dioscoridi L., et al. Endoscopic findings in patients infected with 2019 novel coronavirus in Lombardy, Italy. Clin Gastroenterol Hepatol. 2020;18:2375&#x2013;2377. doi: 10.1016/j.cgh.2020.05.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2020.05.045</ArticleId><ArticleId IdType="pmc">PMC7260560</ArticleId><ArticleId IdType="pubmed">32480008</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie X., Sheng L., Han C., et al. Features of capsule endoscopy in COVID-19 patients with a six-month follow-up: a prospective observational study. J Med Virol. 2022;94:246&#x2013;252. doi: 10.1002/jmv.27308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27308</ArticleId><ArticleId IdType="pmc">PMC8662114</ArticleId><ArticleId IdType="pubmed">34460118</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamakawa T., Ishigami K., Takizawa A., et al. Extensive mucosal sloughing of the small intestine and colon in a patient with severe COVID-19. Den Open. 2022;2:e42. doi: 10.1002/deo2.42.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/deo2.42</ArticleId><ArticleId IdType="pmc">PMC8646689</ArticleId><ArticleId IdType="pubmed">35079746</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizvi A., Patel Z., Liu Y., et al. Gastrointestinal sequelae three and six months after hospitalization for coronavirus disease 2019. Clin Gastroenterol Hepatol. 2021;19:2438&#x2013;2440. doi: 10.1016/j.cgh.2021.06.046. e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2021.06.046</ArticleId><ArticleId IdType="pmc">PMC8245666</ArticleId><ArticleId IdType="pubmed">34217880</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghoshal U.C., Ghoshal U., Rahman M.M., et al. Post-infection functional gastrointestinal disorders following coronavirus disease-19: a case&#x2013;control study. J Gastroenterol Hepatol. 2022;37:489&#x2013;498. doi: 10.1111/jgh.15717.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgh.15717</ArticleId><ArticleId IdType="pmc">PMC8657345</ArticleId><ArticleId IdType="pubmed">34672022</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C., Shi L., Wang F.-S. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol. 2020;5:428&#x2013;430. doi: 10.1016/s2468-1253(20)30057-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2468-1253(20)30057-1</ArticleId><ArticleId IdType="pmc">PMC7129165</ArticleId><ArticleId IdType="pubmed">32145190</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X., Yu Y., Xu J., et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8:475&#x2013;481. doi: 10.1016/s2213-2600(20)30079-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2213-2600(20)30079-5</ArticleId><ArticleId IdType="pmc">PMC7102538</ArticleId><ArticleId IdType="pubmed">32105632</ArticleId></ArticleIdList></Reference><Reference><Citation>Hundt M.A., Deng Y., Ciarleglio M.M., Nathanson M.H., Lim J.K. Abnormal liver tests in COVID-19: a retrospective observational cohort study of 1,827 patients in a major U.S. hospital network. Hepatology. 2020;72:1169&#x2013;1176. doi: 10.1002/hep.31487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.31487</ArticleId><ArticleId IdType="pmc">PMC9258788</ArticleId><ArticleId IdType="pubmed">32725890</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulkarni A.V., Kumar P., Tevethia H.V., et al. Systematic review with meta-analysis: liver manifestations and outcomes in COVID-19. Aliment Pharmacol Therapeut. 2020;52 doi: 10.1111/apt.15916.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apt.15916</ArticleId><ArticleId IdType="pmc">PMC7361465</ArticleId><ArticleId IdType="pubmed">32638436</ArticleId></ArticleIdList></Reference><Reference><Citation>Parasa S., Desai M., Chandrasekar V.T., et al. Prevalence of gastrointestinal symptoms and fecal viral shedding in patients with coronavirus disease 2019. JAMA Netw Open. 2020;3 doi: 10.1001/jamanetworkopen.2020.11335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.11335</ArticleId><ArticleId IdType="pmc">PMC7290409</ArticleId><ArticleId IdType="pubmed">32525549</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar -M.P., Mishra S., Jha D.K., et al. Coronavirus disease (COVID-19) and the liver: a comprehensive systematic review and meta-analysis. Hepatol Int. 2020;14:711&#x2013;722. doi: 10.1007/s12072-020-10071-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12072-020-10071-9</ArticleId><ArticleId IdType="pmc">PMC7335221</ArticleId><ArticleId IdType="pubmed">32623633</ArticleId></ArticleIdList></Reference><Reference><Citation>Yadav D.K., Singh A., Zhang Q., et al. Involvement of liver in COVID-19: systematic review and meta-analysis. Gut. 2021;70:807&#x2013;809. doi: 10.1136/gutjnl-2020-322072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-322072</ArticleId><ArticleId IdType="pmc">PMC7948176</ArticleId><ArticleId IdType="pubmed">32669289</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan W.-J., Ni Z.-Y., Hu Y., et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708&#x2013;1720. doi: 10.1056/nejmoa2002032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang B., Zhou X., Qiu Y., et al. Clinical characteristics of 82 cases of death from COVID-19. PLoS One. 2020;15 doi: 10.1371/journal.pone.0235458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0235458</ArticleId><ArticleId IdType="pmc">PMC7347130</ArticleId><ArticleId IdType="pubmed">32645044</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber S., Mayerle J., Irlbeck M., Gerbes A.L. Severe liver failure during SARS-CoV-2 infection. Gut. 2020;69:1365&#x2013;1367. doi: 10.1136/gutjnl-2020-321350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-321350</ArticleId><ArticleId IdType="pubmed">32327526</ArticleId></ArticleIdList></Reference><Reference><Citation>Wander P., Epstein M., Bernstein D. COVID-19 presenting as acute hepatitis. Am J Gastroenterol. 2020;115 doi: 10.14309/ajg.0000000000000660.</Citation><ArticleIdList><ArticleId IdType="doi">10.14309/ajg.0000000000000660</ArticleId><ArticleId IdType="pmc">PMC7172489</ArticleId><ArticleId IdType="pubmed">32301760</ArticleId></ArticleIdList></Reference><Reference><Citation>Melquist S., Estepp K., Aleksandrovich Y., et al. COVID-19 presenting as fulminant hepatic failure. Medicine. 2020;99 doi: 10.1097/md.0000000000022818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/md.0000000000022818</ArticleId><ArticleId IdType="pmc">PMC7581048</ArticleId><ArticleId IdType="pubmed">33120805</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiel M.I., Jamal S.M.E., Paniz-Mondolfi A., et al. Findings of hepatic severe acute respiratory syndrome coronavirus-2 infection. Cell Mol Gastroenterol Hepatol. 2021;11:763&#x2013;770. doi: 10.1016/j.jcmgh.2020.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmgh.2020.09.015</ArticleId><ArticleId IdType="pmc">PMC7521427</ArticleId><ArticleId IdType="pubmed">32992052</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong J.K., Chopra S., Kahn J.A., Kim B., Khemichian S. Autoimmune hepatitis triggered by COVID-19. Intern Med J. 2021;51:1182&#x2013;1183. doi: 10.1111/imj.15420.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imj.15420</ArticleId><ArticleId IdType="pmc">PMC8447478</ArticleId><ArticleId IdType="pubmed">34278694</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartoli A., Gitto S., Sighinolfi P., Cursaro C., Andreone P. Primary biliary cholangitis associated with SARS-CoV2 infection. J Hepatol. 2021;74:1245&#x2013;1246. doi: 10.1016/j.jhep.2021.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2021.02.006</ArticleId><ArticleId IdType="pmc">PMC7892314</ArticleId><ArticleId IdType="pubmed">33610679</ArticleId></ArticleIdList></Reference><Reference><Citation>Lubnow M., Schmidt B., Fleck M., et al. Secondary hemophagocytic lymphohistiocytosis and severe liver injury induced by hepatic SARS-CoV-2 infection unmasking Wilson's disease: balancing immunosuppression. Int J Infect Dis. 2021;103:624&#x2013;627. doi: 10.1016/j.ijid.2020.12.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.12.047</ArticleId><ArticleId IdType="pmc">PMC7781512</ArticleId><ArticleId IdType="pubmed">33412272</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D., Sun A., Ssentongo A.E., et al. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection. JAMA Netw Open. 2021;4 doi: 10.1001/jamanetworkopen.2021.28568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Edwards K., Allison M., Ghuman S. Secondary sclerosing cholangitis in critically ill patients: a rare disease precipitated by severe SARS-CoV-2 infection. BMJ Case Rep. 2020;13 doi: 10.1136/bcr-2020-237984.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2020-237984</ArticleId><ArticleId IdType="pmc">PMC7654135</ArticleId><ArticleId IdType="pubmed">33168538</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth N.C., Kim A., Vitkovski T., et al. Post&#x2013;COVID-19 cholangiopathy: a novel entity. Am J Gastroenterol. 2021;116:1077&#x2013;1082. doi: 10.14309/ajg.0000000000001154.</Citation><ArticleIdList><ArticleId IdType="doi">10.14309/ajg.0000000000001154</ArticleId><ArticleId IdType="pubmed">33464757</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih A.R., Hatipoglu D., Wilechansky R., et al. Persistent cholestatic injury and secondary sclerosing cholangitis in COVID-19 patients. Arch Pathol Lab Med. 2022 doi: 10.5858/arpa.2021-0605-sa. Online.</Citation><ArticleIdList><ArticleId IdType="doi">10.5858/arpa.2021-0605-sa</ArticleId><ArticleId IdType="pubmed">35657750</ArticleId></ArticleIdList></Reference><Reference><Citation>Faruqui S., Okoli F.C., Olsen S.K., et al. Cholangiopathy after severe COVID-19: clinical features and prognostic implications. Am J Gastroenterol. 2021;116:1414&#x2013;1425. doi: 10.14309/ajg.0000000000001264.</Citation><ArticleIdList><ArticleId IdType="doi">10.14309/ajg.0000000000001264</ArticleId><ArticleId IdType="pubmed">33993134</ArticleId></ArticleIdList></Reference><Reference><Citation>Durazo F.A., Nicholas A.A., Mahaffey J.J., et al. Post&#x2013;COVID-19 cholangiopathy&#x2014;a new indication for liver transplantation: a case report. Transplant Proc. 2021;53:1132&#x2013;1137. doi: 10.1016/j.transproceed.2021.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.transproceed.2021.03.007</ArticleId><ArticleId IdType="pmc">PMC7953456</ArticleId><ArticleId IdType="pubmed">33846012</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou X., Chen K., Zou J., Han P., Hao J., Han Z. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med-Prc. 2020;14:185&#x2013;192. doi: 10.1007/s11684-020-0754-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11684-020-0754-0</ArticleId><ArticleId IdType="pmc">PMC7088738</ArticleId><ArticleId IdType="pubmed">32170560</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M.-Y., Li L., Zhang Y., Wang X.-S. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect&#xa0;Dis Poverty. 2020;9:45. doi: 10.1186/s40249-020-00662-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40249-020-00662-x</ArticleId><ArticleId IdType="pmc">PMC7186534</ArticleId><ArticleId IdType="pubmed">32345362</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Kang Z., Gong H., et al. Digestive system is a potential route of COVID-19: an analysis of single-cell coexpression pattern of key proteins in viral entry process. Gut. 2020;69:1010&#x2013;1018. doi: 10.1136/gutjnl-2020-320953.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-320953</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong M., Zhang J., Ma X., et al. ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19. Biomed Pharmacother. 2020;131 doi: 10.1016/j.biopha.2020.110678.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2020.110678</ArticleId><ArticleId IdType="pmc">PMC7444942</ArticleId><ArticleId IdType="pubmed">32861070</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L., Jiang X., Zhang Z., et al. Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection. Gut. 2020;69:997&#x2013;1001. doi: 10.1136/gutjnl-2020-321013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-321013</ArticleId><ArticleId IdType="pubmed">32241899</ArticleId></ArticleIdList></Reference><Reference><Citation>Stahl K., Br&#xe4;sen J.H., Hoeper M.M., David S. Absence of SARS-CoV-2 RNA in COVID-19-associated intestinal endothelialitis. Intensive Care Med. 2021;47:359&#x2013;360. doi: 10.1007/s00134-020-06326-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06326-6</ArticleId><ArticleId IdType="pmc">PMC7778861</ArticleId><ArticleId IdType="pubmed">33388837</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldsmith C.S., Miller S.E., Martines R.B., Bullock H.A., Zaki S.R. Electron microscopy of SARS-CoV-2: a challenging task. Lancet Lond Engl. 2020;395:e99. doi: 10.1016/s0140-6736(20)31188-0. e99.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(20)31188-0</ArticleId><ArticleId IdType="pmc">PMC7237172</ArticleId><ArticleId IdType="pubmed">32442529</ArticleId></ArticleIdList></Reference><Reference><Citation>Bullock H.A., Goldsmith C.S., Zaki S.R., Martines R.B., Miller S.E. Difficulties in differentiating coronaviruses from subcellular structures in human tissues by electron microscopy. Emerg Infect Dis. 2021;27:1023&#x2013;1031. doi: 10.3201/eid2704.204337.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2704.204337</ArticleId><ArticleId IdType="pmc">PMC8007326</ArticleId><ArticleId IdType="pubmed">33600302</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamers M.M., Beumer J., van der Vaart J., et al. SARS-CoV-2 productively infects human gut enterocytes. Science. 2020;369:50&#x2013;54. doi: 10.1126/science.abc1669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc1669</ArticleId><ArticleId IdType="pmc">PMC7199907</ArticleId><ArticleId IdType="pubmed">32358202</ArticleId></ArticleIdList></Reference><Reference><Citation>Pirola C.J., Sookoian S. SARS-CoV-2 virus and liver expression of host receptors: putative mechanisms of liver involvement in COVID-19. Liver Int. 2020;40 doi: 10.1111/liv.14500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/liv.14500</ArticleId><ArticleId IdType="pmc">PMC7267350</ArticleId><ArticleId IdType="pubmed">32352224</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi F., Qian S., Zhang S., Zhang Z. Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses. Biochem Bioph Res Co. 2020;526:135&#x2013;140. doi: 10.1016/j.bbrc.2020.03.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2020.03.044</ArticleId><ArticleId IdType="pmc">PMC7156119</ArticleId><ArticleId IdType="pubmed">32199615</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L., Han Y., Nilsson-Payant B.E., et al. A human pluripotent stem cell-based platform to study SARS-CoV-2 tropism and model virus infection in human cells and organoids. Cell Stem Cell. 2020;27:125&#x2013;136. doi: 10.1016/j.stem.2020.06.015. e7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2020.06.015</ArticleId><ArticleId IdType="pmc">PMC7303620</ArticleId><ArticleId IdType="pubmed">32579880</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamming I., Timens W., Bulthuis M., Lely A., Navis G., Goor H van. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203:631&#x2013;637. doi: 10.1002/path.1570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1570</ArticleId><ArticleId IdType="pmc">PMC7167720</ArticleId><ArticleId IdType="pubmed">15141377</ArticleId></ArticleIdList></Reference><Reference><Citation>Fassan M., Mescoli C., Sbaraglia M., et al. Liver histopathology in COVID-19 patients: a mono-Institutional series of liver biopsies and autopsy specimens. Pathol Res Pract. 2021;221:153451. doi: 10.1016/j.prp.2021.153451. 153451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.prp.2021.153451</ArticleId><ArticleId IdType="pmc">PMC8054534</ArticleId><ArticleId IdType="pubmed">33932720</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaltschmidt B., Fitzek A.D.E., Schaedler J., et al. Hepatic vasculopathy and regenerative responses of the liver in fatal cases of COVID-19. Clin Gastroenterol Hepatol. 2021;19:1726&#x2013;1729. doi: 10.1016/j.cgh.2021.01.044. e3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2021.01.044</ArticleId><ArticleId IdType="pmc">PMC7844358</ArticleId><ArticleId IdType="pubmed">33516952</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagana S.M., Kudose S., Iuga A.C., et al. Hepatic pathology in patients dying of COVID-19: a series of 40 cases including clinical, histologic, and virologic data. Mod Pathol. 2020:1&#x2013;9. doi: 10.1038/s41379-020-00649-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41379-020-00649-x</ArticleId><ArticleId IdType="pmc">PMC7424245</ArticleId><ArticleId IdType="pubmed">32792598</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao C.L., Rapkiewicz A., Maghsoodi-Deerwester M., et al. Pathological findings in the postmortem liver of patients with coronavirus disease 2019 (COVID-19) Hum Pathol. 2021;109:59&#x2013;68. doi: 10.1016/j.humpath.2020.11.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humpath.2020.11.015</ArticleId><ArticleId IdType="pmc">PMC7722493</ArticleId><ArticleId IdType="pubmed">33307078</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu H., Peng L., Hu L., et al. Liver Histopathological analysis of 24 postmortem findings of patients with COVID-19 in China. Front Med. 2021;8 doi: 10.3389/fmed.2021.749318.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.749318</ArticleId><ArticleId IdType="pmc">PMC8543004</ArticleId><ArticleId IdType="pubmed">34708059</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinz N., Griesemer A., Kinney J., et al. A case of an Infant with SARS-CoV-2 hepatitis early after liver transplantation. Pediatr Transplant. 2020 doi: 10.1111/petr.13778.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/petr.13778</ArticleId><ArticleId IdType="pmc">PMC7323125</ArticleId><ArticleId IdType="pubmed">32559354</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui V.C.-H., Hui K.P.-Y., Babu R.O., et al. Human liver organoid derived intra-hepatic bile duct cells support SARS-CoV-2 infection and replication. Sci Rep-UK. 2022;12:5375. doi: 10.1038/s41598-022-09306-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-09306-6</ArticleId><ArticleId IdType="pmc">PMC8965546</ArticleId><ArticleId IdType="pubmed">35354880</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Ren X., Lu J., et al. Mechanistic insight of SARS-CoV-2 infection using human hepatobiliary organoids. Gut. 2022 doi: 10.1136/gutjnl-2021-326617. gutjnl-2021-326617.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-326617</ArticleId><ArticleId IdType="pmc">PMC9763169</ArticleId><ArticleId IdType="pubmed">35459707</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Liu S., Liu H., et al. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19. J Hepatol. 2020;73:807&#x2013;816. doi: 10.1016/j.jhep.2020.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2020.05.002</ArticleId><ArticleId IdType="pmc">PMC7211738</ArticleId><ArticleId IdType="pubmed">32437830</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao B., Ni C., Gao R., et al. Recapitulation of SARS-CoV-2 infection and cholangiocyte damage with human liver ductal organoids. Protein Cell. 2020;11:771&#x2013;775. doi: 10.1007/s13238-020-00718-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-020-00718-6</ArticleId><ArticleId IdType="pmc">PMC7164704</ArticleId><ArticleId IdType="pubmed">32303993</ArticleId></ArticleIdList></Reference><Reference><Citation>Calitri C., Fumi I., Ignaccolo M.G., et al. Gastrointestinal involvement in paediatric COVID-19 &#x2014; from pathogenesis to clinical management: a comprehensive review. World J Gastroenterol. 2021;27:3303&#x2013;3316. doi: 10.3748/wjg.v27.i23.3303.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v27.i23.3303</ArticleId><ArticleId IdType="pmc">PMC8218363</ArticleId><ArticleId IdType="pubmed">34163113</ArticleId></ArticleIdList></Reference><Reference><Citation>Geier A., Fickert P., Trauner M. Mechanisms of Disease: mechanisms&#xa0;and clinical implications of cholestasis in sepsis. Nat Clin Pract Gastr. 2006;3:574&#x2013;585. doi: 10.1038/ncpgasthep0602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncpgasthep0602</ArticleId><ArticleId IdType="pubmed">17008927</ArticleId></ArticleIdList></Reference><Reference><Citation>Horvatits T., Drolz A., Trauner M., Fuhrmann V. Liver injury and failure in critical illness. Hepatology. 2019;70:2204&#x2013;2215. doi: 10.1002/hep.30824.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.30824</ArticleId><ArticleId IdType="pubmed">31215660</ArticleId></ArticleIdList></Reference><Reference><Citation>Monti S., Balduzzi S., Delvino P., Bellis E., Quadrelli V.S., Montecucco C. Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies. Ann Rheum Dis. 2020;79:667. doi: 10.1136/annrheumdis-2020-217424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-217424</ArticleId><ArticleId IdType="pmc">PMC7211079</ArticleId><ArticleId IdType="pubmed">32241793</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams D.H., Hubscher S.G. Systemic viral infections and collateral damage in the liver. Am J Pathol. 2006;168:1057&#x2013;1059. doi: 10.2353/ajpath.2006.051296.</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2006.051296</ArticleId><ArticleId IdType="pmc">PMC1606546</ArticleId><ArticleId IdType="pubmed">16565481</ArticleId></ArticleIdList></Reference><Reference><Citation>Polakos N.K., Cornejo J.C., Murray D.A., et al. Kupffer cell-dependent hepatitis occurs during influenza infection. Am J Pathol. 2006;168:1169&#x2013;1178. doi: 10.2353/ajpath.2006.050875.</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2006.050875</ArticleId><ArticleId IdType="pmc">PMC1606556</ArticleId><ArticleId IdType="pubmed">16565492</ArticleId></ArticleIdList></Reference><Reference><Citation>Belz G.T., Altman J.D., Doherty P.C. Characteristics of virus-specific CD8+ T cells in the liver during the control and resolution phases of influenza pneumonia. Proc Natl Acad Sci USA. 1998;95:13812&#x2013;13817. doi: 10.1073/pnas.95.23.13812.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.95.23.13812</ArticleId><ArticleId IdType="pmc">PMC24906</ArticleId><ArticleId IdType="pubmed">9811883</ArticleId></ArticleIdList></Reference><Reference><Citation>Parry A.H., Wani A.H., Yaseen M. Acute mesenteric ischemia in severe coronavirus-19 (COVID-19): possible mechanisms and diagnostic pathway. Acad Radiol. 2020;27:1190. doi: 10.1016/j.acra.2020.05.016. 1190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.acra.2020.05.016</ArticleId><ArticleId IdType="pmc">PMC7245306</ArticleId><ArticleId IdType="pubmed">32475635</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z., Shi L., Wang Y., et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir&#xa0;Med. 2020;8:420&#x2013;422. doi: 10.1016/s2213-2600(20)30076-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2213-2600(20)30076-x</ArticleId><ArticleId IdType="pmc">PMC7164771</ArticleId><ArticleId IdType="pubmed">32085846</ArticleId></ArticleIdList></Reference><Reference><Citation>Barton L.M., Duval E.J., Stroberg E., Ghosh S., Mukhopadhyay S. COVID-19 autopsies, Oklahoma, USA. Am J Clin Pathol. 2020;153 doi: 10.1093/ajcp/aqaa062. aqaa062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcp/aqaa062</ArticleId><ArticleId IdType="pmc">PMC7184436</ArticleId><ArticleId IdType="pubmed">32275742</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellosta R., Luzzani L., Natalini G., et al. Acute limb ischemia in patients with COVID-19 pneumonia. J Vasc Surg. 2020;72:1864&#x2013;1872. doi: 10.1016/j.jvs.2020.04.483.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2020.04.483</ArticleId><ArticleId IdType="pmc">PMC7188654</ArticleId><ArticleId IdType="pubmed">32360679</ArticleId></ArticleIdList></Reference><Reference><Citation>Erdinc B., Sahni S., Gotlieb V. Hematological manifestations and complications of COVID-19. Adv Clin Exp Med. 2021;30:101&#x2013;107. doi: 10.17219/acem/130604.</Citation><ArticleIdList><ArticleId IdType="doi">10.17219/acem/130604</ArticleId><ArticleId IdType="pubmed">33529513</ArticleId></ArticleIdList></Reference><Reference><Citation>Westerhoff M., Jones D., Hrycaj S.M., et al. Gastrointestinal pathology in samples from coronavirus disease 2019 (COVID-19)&#x2013;Positive patients. Arch Pathol Lab Med. 2021;145:1062&#x2013;1068. doi: 10.5858/arpa.2021-0137-sa.</Citation><ArticleIdList><ArticleId IdType="doi">10.5858/arpa.2021-0137-sa</ArticleId><ArticleId IdType="pubmed">33961007</ArticleId></ArticleIdList></Reference><Reference><Citation>Amarapurkar A.D., Vichare P., Pandya N., Deshpande S. Haemorrhagic enteritis and COVID-19: causality or coincidence. J Clin Pathol. 2020;73:686. doi: 10.1136/jclinpath-2020-206743. 686.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jclinpath-2020-206743</ArticleId><ArticleId IdType="pmc">PMC7513254</ArticleId><ArticleId IdType="pubmed">32482887</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu C., Sarwal A., Mon A., Tan Y., Shah V. Gastrointestinal: COVID-19 related ischemic bowel disease. J Gastroenterol Hepatol. 2021;36:850. doi: 10.1111/jgh.15254. 850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgh.15254</ArticleId><ArticleId IdType="pubmed">32985002</ArticleId></ArticleIdList></Reference><Reference><Citation>Gartland R.M., Velmahos G.C. Bowel necrosis in the setting of COVID-19. J Gastrointest Surg. 2020;24:2888&#x2013;2889. doi: 10.1007/s11605-020-04632-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11605-020-04632-4</ArticleId><ArticleId IdType="pmc">PMC7196179</ArticleId><ArticleId IdType="pubmed">32363540</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwabejire J.O., Kaafarani H.M.A., Mashbari H., et al. Bowel ischemia in COVID-19 infection: one-year surgical experience. Am Surg. 2021;87:1893&#x2013;1900. doi: 10.1177/00031348211038571.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/00031348211038571</ArticleId><ArticleId IdType="pubmed">34772281</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang J.H.Q., Tang J.H., Eugene-Fan B., Lee C.L., Low J.K. A peculiar case of small bowel stricture in a COVID-19 patient with congenital adhesion band and superior mesenteric vein thrombosis. Ann Vasc Surg. 2020;70:286&#x2013;289. doi: 10.1016/j.avsg.2020.08.084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.avsg.2020.08.084</ArticleId><ArticleId IdType="pmc">PMC7453213</ArticleId><ArticleId IdType="pubmed">32861849</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmit G., Lelotte J., Vanhaebost J., Horsmans Y., Bockstal M.V., Baldin P. The liver in COVID-19-related death: protagonist or innocent bystander? Pathobiology. 2021;88:88&#x2013;94. doi: 10.1159/000512008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000512008</ArticleId><ArticleId IdType="pmc">PMC7705929</ArticleId><ArticleId IdType="pubmed">33108789</ArticleId></ArticleIdList></Reference><Reference><Citation>Chornenkyy Y., Mejia-Bautista M., Brucal M., et al. Liver pathology and SARS-CoV-2 detection in formalin-fixed tissue of patients with COVID-19a single-institution experience. Am J Clin Pathol. 2021;155 doi: 10.1093/ajcp/aqab009. aqab009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcp/aqab009</ArticleId><ArticleId IdType="pmc">PMC8135761</ArticleId><ArticleId IdType="pubmed">33914058</ArticleId></ArticleIdList></Reference><Reference><Citation>Beigmohammadi M.T., Jahanbin B., Safaei M., et al. Pathological findings of postmortem biopsies from lung, heart, and liver of 7 deceased COVID-19 patients. Int J Surg Pathol. 2021;29:135&#x2013;145. doi: 10.1177/1066896920935195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1066896920935195</ArticleId><ArticleId IdType="pmc">PMC8041443</ArticleId><ArticleId IdType="pubmed">32552178</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonzogni A., Previtali G., Seghezzi M., et al. Liver histopathology in severe COVID 19 respiratory failure is suggestive of vascular alterations. Liver Int. 2020;40:2110&#x2013;2116. doi: 10.1111/liv.14601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/liv.14601</ArticleId><ArticleId IdType="pmc">PMC7404964</ArticleId><ArticleId IdType="pubmed">32654359</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Q., Huang D., Yu H., et al. Characteristics of liver tests in COVID-19 patients. J Hepatol. 2020;73:566&#x2013;574. doi: 10.1016/j.jhep.2020.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2020.04.006</ArticleId><ArticleId IdType="pmc">PMC7194951</ArticleId><ArticleId IdType="pubmed">32298767</ArticleId></ArticleIdList></Reference><Reference><Citation>Pirisi M., Rigamonti C., D'Alfonso S., et al. Liver infection and COVID-19: the electron microscopy proof and revision of the literature. Eur Rev Med Pharmaco. 2021;25:2146&#x2013;2151. doi: 10.26355/eurrev_202102_25120.</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202102_25120</ArticleId><ArticleId IdType="pubmed">33660834</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagana S.M., Michele S.D., Lee M.J., et al. COVID-19&#x2013;associated hepatitis complicating recent living donor liver transplantation. Arch Pathol Lab Med. 2020;144:929&#x2013;932. doi: 10.5858/arpa.2020-0186-sa.</Citation><ArticleIdList><ArticleId IdType="doi">10.5858/arpa.2020-0186-sa</ArticleId><ArticleId IdType="pubmed">32302212</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih A.R., Naini B.V., Westerhoff M.M., Alpert M.L., Masia M.R., Misdraji M.J. Cytomegalovirus hepatitis in allograft livers may show histologic features of acute cellular rejection. Arch Pathol Lab Med. 2022 doi: 10.5858/arpa.2021-0551-OA. In press.</Citation><ArticleIdList><ArticleId IdType="doi">10.5858/arpa.2021-0551-OA</ArticleId><ArticleId IdType="pubmed">36084247</ArticleId></ArticleIdList></Reference><Reference><Citation>Maconi G., Bosetti C., Monti A.D., et al. Risk of COVID 19 in patients with inflammatory bowel diseases compared to a control population. Dig Liver Dis. 2021;53:263&#x2013;270. doi: 10.1016/j.dld.2020.12.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dld.2020.12.013</ArticleId><ArticleId IdType="pmc">PMC7762705</ArticleId><ArticleId IdType="pubmed">33483259</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh S., Khan A., Chowdhry M., Bilal M., Kochhar G.S., Clarke K. Risk of severe coronavirus disease 2019 in patients with inflammatory bowel disease in the United States: a multicenter research network study. Gastroenterology. 2020;159:1575&#x2013;1578. doi: 10.1053/j.gastro.2020.06.003. e4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.06.003</ArticleId><ArticleId IdType="pmc">PMC7702184</ArticleId><ArticleId IdType="pubmed">32522507</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner E.J., Ungaro R.C., Gearry R.B., et al. Corticosteroids, but not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: results from an international registry. Gastroenterology. 2020;159:481&#x2013;491. doi: 10.1053/j.gastro.2020.05.032. e3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.05.032</ArticleId><ArticleId IdType="pmc">PMC7233252</ArticleId><ArticleId IdType="pubmed">32425234</ArticleId></ArticleIdList></Reference><Reference><Citation>Ungaro R.C., Brenner E.J., Gearry R.B., et al. Effect of IBD medications on COVID-19 outcomes: results from an international registry. Gut. 2021;70:725&#x2013;732. doi: 10.1136/gutjnl-2020-322539.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-322539</ArticleId><ArticleId IdType="pmc">PMC8136807</ArticleId><ArticleId IdType="pubmed">33082265</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzello F., Calabrese C., Salice M., et al. COVID-19 in IBD: the experience of a single tertiary IBD center. Dig Liver Dis. 2021;53:271&#x2013;276. doi: 10.1016/j.dld.2020.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dld.2020.12.012</ArticleId><ArticleId IdType="pmc">PMC7764386</ArticleId><ArticleId IdType="pubmed">33451910</ArticleId></ArticleIdList></Reference><Reference><Citation>Janowitz T., Gablenz E., Pattinson D., et al. Famotidine use and quantitative symptom tracking for COVID-19 in non-hospitalised patients: a case series. Gut. 2020;69:1592&#x2013;1597. doi: 10.1136/gutjnl-2020-321852.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-321852</ArticleId><ArticleId IdType="pmc">PMC7299656</ArticleId><ArticleId IdType="pubmed">32499303</ArticleId></ArticleIdList></Reference><Reference><Citation>Freedberg D.E., Conigliaro J., Wang T.C., et al. Famotidine use is&#xa0;associated with improved clinical outcomes in hospitalized COVID-19 patients: a propensity score matched retrospective cohort study. Gastroenterology. 2020;159:1129&#x2013;1131. doi: 10.1053/j.gastro.2020.05.053. e3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.05.053</ArticleId><ArticleId IdType="pmc">PMC7242191</ArticleId><ArticleId IdType="pubmed">32446698</ArticleId></ArticleIdList></Reference><Reference><Citation>Mather J.F., Seip R.L., McKay R.G. Impact of famotidine use on clinical outcomes of hospitalized patients with COVID-19. Am J Gastroenterol. 2020;115 doi: 10.14309/ajg.0000000000000832.</Citation><ArticleIdList><ArticleId IdType="doi">10.14309/ajg.0000000000000832</ArticleId><ArticleId IdType="pmc">PMC7473796</ArticleId><ArticleId IdType="pubmed">32852338</ArticleId></ArticleIdList></Reference><Reference><Citation>Luxenburger H., Sturm L., Biever P., et al. Treatment with proton pump inhibitors increases the risk of secondary infections and ARDS in hospitalized patients with COVID-19: coincidence or underestimated risk factor? J Intern Med. 2020;289 doi: 10.1111/joim.13121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13121</ArticleId><ArticleId IdType="pmc">PMC7361636</ArticleId><ArticleId IdType="pubmed">32608546</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanc F., Waechter C., Vogel T., et al. Therapeutic prevention of COVID-19 in elderly: a case&#x2013;control study. Geroscience. 2021;43:2333&#x2013;2343. doi: 10.1007/s11357-021-00397-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-021-00397-z</ArticleId><ArticleId IdType="pmc">PMC8285285</ArticleId><ArticleId IdType="pubmed">34273049</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X.-W., Wu X.-X., Jiang X.-G., et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020;368:m606. doi: 10.1136/bmj.m606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m606</ArticleId><ArticleId IdType="pmc">PMC7224340</ArticleId><ArticleId IdType="pubmed">32075786</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Wang Y., Li X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497&#x2013;506. doi: 10.1016/s0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D., Hu B., Hu C., et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus&#x2013;infected pneumonia in Wuhan, China. JAMA. 2020;323:1061&#x2013;1069. doi: 10.1001/jama.2020.1585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.1585</ArticleId><ArticleId IdType="pmc">PMC7042881</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T., Dai Z., Mo P., et al. Clinical characteristics and outcomes of older patients with coronavirus disease 2019 (COVID-19) in Wuhan, China (2019): a single-centered, retrospective study. Journals Gerontology Ser. 2020;75 doi: 10.1093/gerona/glaa089. glaa089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/glaa089</ArticleId><ArticleId IdType="pmc">PMC7184388</ArticleId><ArticleId IdType="pubmed">32279081</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L., Huang S., Yang J., et al. Clinical characteristics in patients with SARS-CoV-2/HBV co-infection. J Viral Hepat. 2020;27:1504&#x2013;1507. doi: 10.1111/jvh.13362.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jvh.13362</ArticleId><ArticleId IdType="pmc">PMC7404861</ArticleId><ArticleId IdType="pubmed">32668494</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji D., Qin E., Xu J., et al. Implication of non-alcoholic fatty liver diseases (NAFLD) in patients with COVID-19: a preliminary analysis. J Hepatol. 2020;73:451&#x2013;453. doi: 10.1016/j.jhep.2020.03.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2020.03.044</ArticleId><ArticleId IdType="pmc">PMC7141624</ArticleId><ArticleId IdType="pubmed">32278005</ArticleId></ArticleIdList></Reference><Reference><Citation>Paizis G., Tikellis C., Cooper M.E., et al. Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2. Gut. 2005;54:1790. doi: 10.1136/gut.2004.062398.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gut.2004.062398</ArticleId><ArticleId IdType="pmc">PMC1774784</ArticleId><ArticleId IdType="pubmed">16166274</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang M., Li X., Meng Y., et al. Upregulation of angiotensin-converting enzyme (ACE) 2 in hepatic fibrosis by ACE inhibitors. Clin Exp Pharmacol. 2010;37:e1&#x2013;e6. doi: 10.1111/j.1440-1681.2009.05302.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1681.2009.05302.x</ArticleId><ArticleId IdType="pubmed">19793108</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Y., Pan H., She Q., Wang F., Chen M. Prevention of SARS-CoV-2 infection in patients with decompensated cirrhosis. Lancet Gastroenterol Hepatol. 2020;5:528&#x2013;529. doi: 10.1016/s2468-1253(20)30080-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2468-1253(20)30080-7</ArticleId><ArticleId IdType="pmc">PMC7270565</ArticleId><ArticleId IdType="pubmed">32197093</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Antiga L. Coronaviruses and immunosuppressed patients: the facts during the third epidemic. Liver Transplant. 2020;26:832&#x2013;834. doi: 10.1002/lt.25756.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lt.25756</ArticleId><ArticleId IdType="pubmed">32196933</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahamid M., Nseir W., Khoury T., et al. Nonalcoholic fatty liver disease is associated with COVID-19 severity independently of metabolic syndrome: a retrospective case-control study. Eur J Gastroenterol Hepatol. 2021;33 doi: 10.1097/MEG.0000000000001902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MEG.0000000000001902</ArticleId><ArticleId IdType="pmc">PMC8555881</ArticleId><ArticleId IdType="pubmed">32868652</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen V.L., Hawa F., Berinstein J.A., et al. Hepatic steatosis is associated with increased disease severity and liver injury in coronavirus disease-19. Dig Dis Sci. 2021;66:3192&#x2013;3198. doi: 10.1007/s10620-020-06618-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10620-020-06618-3</ArticleId><ArticleId IdType="pmc">PMC7520076</ArticleId><ArticleId IdType="pubmed">32980956</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamed D.Z., Ghoneim M.E.-S., Abu-Risha S.E.-S., Abdelsalam R.A., Farag M.A. Gastrointestinal and hepatic diseases during the COVID-19 pandemic: manifestations, mechanism and management. World J Gastroenterol. 2021;27:4504&#x2013;4535. doi: 10.3748/wjg.v27.i28.4504.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v27.i28.4504</ArticleId><ArticleId IdType="pmc">PMC8326263</ArticleId><ArticleId IdType="pubmed">34366621</ArticleId></ArticleIdList></Reference><Reference><Citation>Doyno C., Sobieraj D.M., Baker W.L. Toxicity of chloroquine and hydroxychloroquine following therapeutic use or overdose. Clin Toxicol. 2020;59:12&#x2013;23. doi: 10.1080/15563650.2020.1817479.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15563650.2020.1817479</ArticleId><ArticleId IdType="pubmed">32960100</ArticleId></ArticleIdList></Reference><Reference><Citation>Temple C., Hoang R., Hendrickson R.G. Toxic effects from Ivermectin use associated with prevention and treatment of COVID-19. N Engl J Med. 2021;385:2197&#x2013;2198. doi: 10.1056/nejmc2114907.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmc2114907</ArticleId><ArticleId IdType="pmc">PMC8552535</ArticleId><ArticleId IdType="pubmed">34670041</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruan X., Lu X., Wang K., et al. Liver injury after antiviral treatment of critically ill patients with COVID-19: a single-centered retrospective cohort study. Ann Palliat Med. 2021:32. doi: 10.21037/apm-20-1581. 32.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/apm-20-1581</ArticleId><ArticleId IdType="pubmed">33440980</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambrus C., &#xc9; Bakos, Sarkadi B., &#xd6;zvegy-Laczka C., Telbisz &#xc1;. Interactions of anti-COVID-19 drug candidates with hepatic transporters may cause liver toxicity and affect pharmacokinetics. Sci Rep-UK. 2021;11 doi: 10.1038/s41598-021-97160-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-97160-3</ArticleId><ArticleId IdType="pmc">PMC8426393</ArticleId><ArticleId IdType="pubmed">34497279</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao B., Wang Y., Wen D., et al. A trial of Lopinavir&#x2013;Ritonavir in adults hospitalized with severe COVID-19. N Engl J Med. 2020;382:1787&#x2013;1799. doi: 10.1056/nejmoa2001282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmoa2001282</ArticleId><ArticleId IdType="pmc">PMC7121492</ArticleId><ArticleId IdType="pubmed">32187464</ArticleId></ArticleIdList></Reference><Reference><Citation>Falc&#xe3;o M.B., Cavalcanti LP. de G., Filho N.M.F., Brito CAA de. Case report: hepatotoxicity associated with the use of hydroxychloroquine in a patient with COVID-19. Am J Trop Med Hyg. 2020;102:1214&#x2013;1216. doi: 10.4269/ajtmh.20-0276.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.20-0276</ArticleId><ArticleId IdType="pmc">PMC7253107</ArticleId><ArticleId IdType="pubmed">32314698</ArticleId></ArticleIdList></Reference><Reference><Citation>Makin A.J., Wendon J., Fitt S., Portmann B.C., Williams R. Fulminant hepatic failure secondary to hydroxychloroquine. Gut. 1994;35:569. doi: 10.1136/gut.35.4.569.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gut.35.4.569</ArticleId><ArticleId IdType="pmc">PMC1374814</ArticleId><ArticleId IdType="pubmed">8175002</ArticleId></ArticleIdList></Reference><Reference><Citation>Knooihuizen S.A.I., Aday A., Lee W.M. Ketamine-induced sclerosing cholangitis (KISC) in a critically ill patient with COVID-19. Hepatology. 2021 doi: 10.1002/hep.31650.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.31650</ArticleId><ArticleId IdType="pmc">PMC7753245</ArticleId><ArticleId IdType="pubmed">33226658</ArticleId></ArticleIdList></Reference><Reference><Citation>Khatib M.Y., Shaik K.S., Ahmed A.A., et al. Tocilizumab-induced cytomegalovirus colitis in a patient with COVID-19. Clin Case Reports. 2021;9:148&#x2013;152. doi: 10.1002/ccr3.3487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccr3.3487</ArticleId><ArticleId IdType="pmc">PMC7813092</ArticleId><ArticleId IdType="pubmed">33489151</ArticleId></ArticleIdList></Reference><Reference><Citation>Carll W.C., Rady M.Y., Salomao M.A., Patel B., Singh V.P., Sen A. Cytomegalovirus haemorrhagic enterocolitis associated with severe infection with COVID-19. BMJ Open Gastroenterol. 2021;8 doi: 10.1136/bmjgast-2020-000556.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgast-2020-000556</ArticleId><ArticleId IdType="pmc">PMC7804824</ArticleId><ArticleId IdType="pubmed">33436481</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghielmetti M., Schaufelberger H.D., Mieli-Vergani G., et al. Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: a novel clinical entity? J Autoimmun. 2021;123 doi: 10.1016/j.jaut.2021.102706.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2021.102706</ArticleId><ArticleId IdType="pmc">PMC8279947</ArticleId><ArticleId IdType="pubmed">34293683</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrido I., Lopes S., Sim&#xf5;es M.S., et al. Autoimmune hepatitis&#xa0;after&#xa0;COVID-19 vaccine &#x2013; more than a coincidence. J Autoimmun. 2021;125:102741. doi: 10.1016/j.jaut.2021.102741. 102741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2021.102741</ArticleId><ArticleId IdType="pmc">PMC8547941</ArticleId><ArticleId IdType="pubmed">34717185</ArticleId></ArticleIdList></Reference><Reference><Citation>Palla P., Vergadis C., Sakellariou S., Androutsakos T. Letter to the editor: autoimmune hepatitis after COVID-19 vaccination: a rare adverse effect? Hepatology. 2022;75:489&#x2013;490. doi: 10.1002/hep.32156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.32156</ArticleId><ArticleId IdType="pmc">PMC8653275</ArticleId><ArticleId IdType="pubmed">34528278</ArticleId></ArticleIdList></Reference><Reference><Citation>Bril F., Diffalha S.A., Dean M., Fettig D.M. Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) Vaccine: causality or casualty? J Hepatol. 2021;75:222&#x2013;224. doi: 10.1016/j.jhep.2021.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2021.04.003</ArticleId><ArticleId IdType="pmc">PMC8056822</ArticleId><ArticleId IdType="pubmed">33862041</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou T., Fronhoffs F., Dold L., Strassburg C.P., Weism&#xfc;ller T.J. New-onset autoimmune hepatitis following mRNA COVID-19 vaccination in a 36-year-old woman with primary sclerosing cholangitis &#x2013; should we be more vigilant? J Hepatol. 2021;76:218&#x2013;220. doi: 10.1016/j.jhep.2021.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2021.08.006</ArticleId><ArticleId IdType="pmc">PMC8384483</ArticleId><ArticleId IdType="pubmed">34450237</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>